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Abstract 
The colonization of a healthy gastrointestinal (GI) tract is a primary target for HIV infection. 
HIV infection causes inflammation, which results in disruption of the mucosal surface of the 
gut and the breakdown of the gut wall integrity which causes the free flow of pathogenic 
microbes to the lymph nodes. HIV infection causes alteration of gut microbiota in affected 
subjects, compared with healthy subjects. However the pattern of gut microbiota depends on 
many variables. Studies supported that probiotic supplement could bring back the normal gut 
microbiota to some extent as well as possibly suppressing pro inflammatory responses. This 
study is aimed at investigating the relationship between the gut microbiota and HIV infection 
progression in the Swedish patients. There were fifteensubjects under this study and divided 
into five groups (three subjects in each) such as Baseline, Follow up, Elite control, Immune-
deficient and Control. One subject of Elite control was rejected as it was failed QC of MG-
RAST.The analysis of gut microbiota is carried out through library preparation and 
sequencing using theNextera XT DNA kit and MiSeqsystem, respectivelyat the in Norwegian 
Univeristyof Life Science. The taxonomical and functional abundance was analyzed by the 
help of the MG-RAST pipeline. The abundance between groups were significantly different 
in different taxonomical levels from phylum to genus. Firmicuteswas the only bacterial phyla 
whose abundance was found significantly different between the subject groups. 
Akkermansiamuniciphilawas the only bacterial species which represent the bacterial phylum 
Verrucomicrobia, and weremost abundant in the immune-deficient group. Clostridia, bacteria 
that play a critical role in the body's immune defense mechanism, were less abundant in the 
control group than the infected groups.  Bacterial families showed much more variety of 
abundance among the groups. Bacterial genes functioning for membrane transport, defense, 
virulence and disease were less abundant in immune-deficient group.  
 
Keywords: HIV, gut microbiota, probiotics, MG-RAST, taxonomical abundance, functional 
abundance 
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1. Introduction 
1.1. Human microbiota 
Human body harbors at least 100 trillion microbial cells(Whitman, Coleman, & Wiebe, 1998) 
which is far more than human cells (Goodman & Gordon, 2010) and quadrillion virus within 
and on our body(Haynes and Rohwer, 2011). They constitute the microbiota of human body 
and the genes encoded by them are referred as microbiome(Clemente, Ursell, Parfrey, & 
Knight, 2012). The role of microbiome in health and disease has been revealed by the 
application of advanced genomic processing technology and computational mapping of 
biological data from human microbial environment(Sweeney & Morton, 2013).Apparently 
there area complex interactions among these microbial community and with the host. So it is 
normal that human health and physiology experienced a great impact from this interaction 
(Clemente et al., 2012). Certainly as a consequence microbiota plays key role on human 
health and disease (O'Hara & Shanahan, 2006). Genetics of the host is one of the key factor 
for the establishment and shaping of the gut microbiota because host genomic loci influence 
the bacterial composition (Benson et al., 2010); (Spor, Koren, & Ley, 2011). Bacteria are the 
dominating microbes in the gut microbiota. While Bacteroidetes and Firmicutes are the most 
abundant division of bacteria in the gut (Turnbaugh et al., 2006). There are three types of 
relationship arises between human and bacteria residing into host from the dynamic 
evolutionary process e.g., symbiosis, commensalism and pathogenicity   (Backhed, Ley, 
Sonnenburg, Peterson, & Gordon, 2005). It is estimated that human gut microbiota comprises 
approximately 500-1000 species (Ley, Peterson, & Gordon, 2006), (Dethlefsen, Huse, Sogin, 
& Relman, 2008) among them a small number dominate the community (Arumugam et al., 
2011) which encode 100 folds more unique gene than the human genome(Ley et al., 2006). In 
recent years bacterial component of microbiota studied under large scale projects such as the 
Human Microbiome Projects (Group et al., 2009); (Turnbaugh et al., 2007) and MetaHIT(Qin 
et al., 2010). Accumulating evidence suggested that the gut microbiome has profound roles in 
modulating the host metabolism(Holmes, Li, Athanasiou, Ashrafian, & Nicholson, 2011), 
(Claus et al., 2011), (Diaz Heijtz et al., 2011). The intestinal microflora possess diverse 
complex of functional enzymes that are detrimental and beneficial (Z. J. Shu, Cao, & 
Halmurat, 2011). Gut bacteria plays a role in immune system development(Z. Shu, Ma, 
Tuerhong, Yang, & Upur, 2013). Human gastrointestinal tract can accommodate about half or 
more of our total immune cells in the body (Mowat & Viney, 1997). Interaction between gut 
microbiota and immune system give signals to promote the maturation of immune cells and 
 9 
 
normal development of immune functions(Chow, Lee, Shen, Khosravi, & Mazmanian, 2010). 
There is a proposition that enteric viral replication and systematic pathogenesis has been 
promoted by intestinal microbiota (Kuss et al., 2011).Innate and adaptive immunity both play 
an important role in shaping of gut microbiota composition (Carvalho et al., 2012). Natural 
gut bacteria secrets one type molecule that interacts with the toll-like receptor 4 (TLR-4). 
Furthermore virus can make infection after this interaction (Pennisi, 2011).In the early stage 
of HIV infection, there is a very fast and significant damage to gut associated lymphoid 
tissues (GALTs) with profound depletion of Th17 cells. Intestinal bacterial is controlled by 
Th17 cells, a subset of CD4+ T cells (Brenchley et al., 2004). Depletion of Th17 cells leads 
the microbial translocation in the gastrointestinal tract (Gautreaux, Deitch, & Berg, 1994b) 
and (Gautreaux, Deitch, & Berg, 1994a) 
 
Figure 1.1: Effect of Interactions of Bacteria, Viruses, and Eukaryotes in Health and Disease.―One microbe, one 
disease‖- diseases were studied under this classical concept. Nevertheless now it is well established that a 
complex interaction between bacteria, virus and eukaryotes as well as the drug and some drugs shapes the 
disease phenotypes(Clemente et al., 2012).  
There is a great variation in taxa present in gut along with the interindividual variation. 
Although the microbiota is stable within the individual throughout the life, external 
perturbation e.g., antibiotic can alter the composition by long term decrease in bacterial 
diversity (Clemente et al., 2012). There is a an evidence that reduction of antibiotic resistance 
pathogens following the reduced number of antibiotic treatment (Goossens, Ferech, Vander 
Stichele, Elseviers, & Group, 2005) which postulated that the repeated use of antibiotic can 
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increase the reservoir antibiotic resistance gene in our own microbiome (Sommer, Dantas, & 
Church, 2009) (figure 1.1).   Evidence suggests that bacteria present in the amniotic fluid of 
anotherwith lower numbers and diversity, though babies are considered as sterile in the uterus 
(Jimenez et al., 2008).Immediately upon birth babies experience diverse environments and 
colonized by microbes either from mother‘s vagina or from skin depending on the delivery 
mode of the baby(Adlerberth & Wold, 2009); (Dominguez-Bello et al., 2010). Babies born 
normally have the vaginal microbiota present in their mother(figure 1.2). On the other hand 
caesarean babies have communities resemble to the skin(Dominguez-Bello et al., 2010). 
Caesarean babies have lower bacterial cells counts in their fecal samples but their antibody 
secreting cells are higher. Thus it is assumed that gut microbiota development influence the 
immunological development during the first year of life(Huurre et al., 2008).Initially the 
bacterial and viral load in the infant gut is low, and then there is a sharp increase during early 
development(Adlerberth & Wold, 2009); (Breitbart et al., 2008); (Koenig et al., 2011) and 
(Vaishampayan et al., 2010). It takes approximately 1.5 years to reach an adult like the 
bacterial composition in the gut, which starts from the end first year of life (Palmer, Bik, 
DiGiulio, Relman, & Brown, 2007)that is stable throughout the life(figure1.2) 
 
Figure 1.2: Development of microbiota during the life time(Clemente et al., 2012).The newborn baby is 
colonized while its gastrointestinal tract is sterile when it was in fetus status. The colonization varies either 
vaginal or skin like pattern of mother depending upon its delivery mode. The reduced activity of Toll-Like 
Receptor (TLR) allows the formation of stable bacterial microbiota in the gut during first 4 weeks of birth. The 
community goes towards an adult like pattern as the baby grows up. During this period the immune system can 
recognize the commensal and pathogenic bacteria. Although different disease conditions can change the pattern 
of microbiota of the gut despite it is quite stable during adulthood where Bacteroidetes and Firmicutes are most 
abundant divisions (Clemente et al., 2012).  
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1.2.Host immune system and microbiota: 
The mammalian immune system specially the mucosal immune system in human has a 
complex correlation with his microbiota.IgA plays a fundamental role in mucosal immunity 
(Clemente et al., 2012). The colonization of specific commensal bacteria can induce IgA and 
protects mucosal surfaces and contribute to host-microbiota mutuality (Bouskra et al., 2008); 
(Macpherson, Geuking, & McCoy, 2011) and (Peterson, McNulty, Guruge, & Gordon, 2007). 
An experiment on germ free mice with reduced gut secretary IgA, showed deficiency in gut-
associated lymphoid tissue during developmental stage, smaller Peyer‘s patches and 
mesenteric lymph nodes (Round & Mazmanian, 2009). Bacterial cell wall (lipopolisaccharide 
and peptidoglycane) and flagellin contains specific microbe-associated molecular patters 
(MAMPs) those are recognized by innate immune system. Host uses several proteins e.g., 
Toll-like receptors (TLRs) to recognize these types of antigens.  The gut and mucosal 
immune system do not response properly if these proteins are absent or mutated (O'Hara & 
Shanahan, 2006).  The commensal bacteria interact with TLRs to suppress the inflammatory 
response and improve the immunological tolerance (O'Hara & Shanahan, 2006) and (Round 
et al., 2011).There is different multi-protein complexes (inflammasomes) expressed in 
myeloid cells (Martinon, Burns, & Tschopp, 2002). As they are responsible for the activation 
of inflammatory process (Mariathasan et al., 2004)  these multi-protein oligomers can sense 
exogenous and endogenous damage associated molecular patterns. NOD-like receptors 
(NLRs) recognize microbial molecules and can form inflammasomes. Reduced level of IL-18 
has been observed as a consequence of deficient NLPRP6 which results alteration in 
microbiota and intestinal hyperplasia (Elinav et al., 2011). Commensal microbiota can also 
modulate the host adaptive immune system. Differentiation of T-cell population can also be 
affected by the microbiota within the host (Lathrop et al., 2011).  
1.3.Microbial translocation: 
In pathogenic human immunodeficiency virus (HIV) infections, microbial translocations are 
proposed to be an important influential event in chronic immune activation. Disease 
progression is closely associated with the disease progression.  A series of immune 
pathological events takes place in the gastrointestinal tract prior to HIV associated microbial 
translocation. The early and severe mucosal CD4
+
 depletion, hyperactivity of mucosal 
immune system, disruption in intestinal epithelium integrity along with enterocyte apoptosis 
and tight junction disruption and finally downfall of microbiome where the opportunistic 
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bacteria dominate the community (Marchetti, Tincati, & Silvestri, 2013). In normal condition 
the gastrointestinal tract is functionally and anatomically integrates. Hence the translocating 
microorganisms and microbial products are phagosytosed within the lamina propia and 
mesenteric lymph nodes. In contrary microbial translocation is a nonphysiological passage of 
gastrointestinal microflora and microbial products through the breach of intestinal epithelial 
barrier and lamina propia and in the end local mesenteric lymph nodes and finally to the 
systemic circulation (Wolochow, Hildebrand, & Lamanna, 1966), (Fuller & Jayne-Williams, 
1970a) and (Fuller & Jayne-Williams, 1970b). Hence microbial translocation modifies the 
gut microbiome by antibiotics, pre and probiotics as well as transfer of microbial bioproducts 
from the gut (figure 1.3). In addition to it can reduce mucosal immune activation such as IL-
7, IL-17 and IL-22 (Marchetti et al., 2013). 
  
Figure 1.3: HIV associated damage to the gastrointestinal tract. (A) The gastrointestinal mucosal barrier of a 
healthy, HIV-negative subject is anatomically and functionally integrated is such a way that microbial 
translocation induces mucosal immune activation and limits the microbial translocation to the peripheral blood. 
(B) On the other hand HIV-positive patients have intestinal barrier which loses its tight junctions, enterocyte 
apoptosis, local immune activation and depletion of CD4+ Th17 cells. Therefore pathogenic bacteria and 
microbial products are translocated from the gut lumen to systemic circulation through lamina propia(Marchetti 
et al., 2013).  
1.3.1. Immune activation due to microbial translocation: 
Microbial translocation results T-cell activation. Subsequently, it persuades the HIV disease 
progression. Chronically HIV-infected patients exhibit higher level of circulating LPS than 
the HIV negative individuals suggesting increased level of microbial translocation in the 
patients. The LPS level in plasma has positive correlation with innate and adaptive immune 
 13 
 
activation (Brenchley et al., 2006).  Another in vitro experiment showed that exposure of 
microbial TLR ligands affect T-lymphocyte activation thus increase the immune activation to 
the extreme level in the HIV- infected patients.  Thus microbial translocation is a critical 
factor for immune activation (Funderburg et al., 2008). 
1.3.2. Characterization of stool microbiota in association with translocating flora in 
HIV infected patients:  
Gut microbiota has a profound effect on the maintenance of immunity and health. To 
maintain both local and systemic immunity in the normal state it is important that the 
composition of gut microbiota should to be specific(Paiardini, Frank, Pandrea, Apetrei, & 
Silvestri, 2008).  Experiments on germ free mice showed that it gains different components of 
mucosal immunity after the repopulation of microbial flora in the gut(Tlaskalova-Hogenova 
et al., 2004) and (Umesaki, Okada, Matsumoto, Imaoka, & Setoyama, 1995) although it is 
difficult to determine the magnitude of the effects or causes of gut microbiota in different 
disease conditions. But in the animal models the gut microbiota has been altered dramatically 
both quantitative and compositional level(McKenna et al., 2008). In the early stages of HIV 
infection patients exhibit damaged fecal flora than the normal condition where it is dominated 
by the pathogens such asPseudomonas aeruginosa and Candida albicans then the beneficial 
bacteria such as bifidobacteria and lactobacilli(Gori et al., 2008). HIV positive patients have 
higher contribution of proinflammatory/ inflammatory inducing bacterial order, 
e.g.,EnterobacterialesandBacteroidales in their gut compared to healthy controls.Deudenal 
T-cell activation is negatively correlated with the stool bacterial load. The duodenal CD4+ T-
cell loss and peripheral CD8+ T-cell activation has been identified by the level of fecal DNA 
of bacterial order EnterobacterialesandBacteroidales(Ellis et al., 2011). Another study 
demonstrated that after the ART treatment on HIV patient's gut has enriched withimmune 
modulator and antiinflammatory bacterial family Enterobacteriaceae(Merlini et al., 2011).  
1.3.3. Modification of gastrointestinal microbiota as a treatment of microbial 
translocation:  
Probiotics are living microorganism which upon administration provides beneficial health 
benefits to the host (Reid, 2010) by inhibiting proinflammatory cytokines, decreasing gut 
permeability and stimulating the mucosal immunity (Marchetti et al., 2013). Therefore beside 
antibiotic treatment the use of probiotics is considered as an alternative way to alter the gut 
microbiota. Studies on HIV-infected patients in Tanzania demonstrated that probiotic yogurt 
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consumption was associated with CD4
+
 T-cell augmentation (Irvine et al., 2010). Another 
studies demonstrated that ART along with probiotic supplementation provide a benefits to the 
SIV infected macaque by increment of antigen presenting cell frequency and function, 
enhanced T-cell immunity in intestinal mucosa, Th17 cells becoming more polyfuctional and 
reduces T-cell activation (Klatt et al., 2012).  
1.4.Response of gastrointestinal immune system to the HIV infection: 
The mucosal surface of the gastrointestinal tract serves as a protective barriers as a part of 
body‘s immune system. In addition to this mucosal immune system contains the greater part 
of the body‘s T-cells. HIV specific CD8+ T-cells plays a role in controlling the viral 
replication which persists in chronic infection (Koup et al., 1994). Experiments suggested 
that gastrointestinal tract is a major site of HIV replication following infection to the mucosal 
surface which results destruction of CD4
+
 T-cell (Brenchley & Douek, 2008) due to weaker 
immune activity in gut. It is assumed that the CD4+ T-cells in the gastrointestinal tract are 
infected, 10 times more by the virus than the peripheral blood(Mehandru et al., 2007).  
1.5.Effect of probiotics on gastrointestinal tract of HIV patients: 
In the early stage of HIV disease the level of gut CD4+ Th17 declines in response to the 
alteration of the gut in normalmicroflora. A study of model animal having inflammatory 
bowel disease showed that combination of probiotic bacteria can up regulate the 
Tregactivation, which suppress the proinflammatory immune response in the animals. 
Preliminary studies showed that probiotic supplements enhance the growth and protection of 
CD4+ T-cells(Cunningham-Rundles et al., 2011). Therefore, it is assumed that probiotic 
bacteria can provide benefit in HIV treatment specially children who were infected before the 
development of their gut flora(Dicks, Fraser, ten Doeschate, & van Reenen, 2009).  
1.6.Metagenomics: 
In Greek, meta means ―transcendent‖. In the field of microbial ecology metagenomics is one 
of the most remarkable events to understand the microbial genetic recourses in a given 
environment. It is a combination of genomic technologies and Bioinformatics tools. Hence 
metagenomics enables the researchers to analyze the functional gene composition in addition 
to this phylogenetic analysis of a microbial community.  There are a huge number of 
microorganisms which are not culturable. So to understand the above mentioned composition 
of a microbial community, it is necessary to get genetic information from all microorganisms 
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present over there.  The great potentiality of metagenomics is that it overcomes this 
limitation, therefore researchers can go through all the genetic information from culturable or 
unculturable microorganism under examination. A typical sequence-based metagenomics 
study involves sampling, processing for DNA sequencing, assembly, binning, annotation and 
analysis.  
1.6.1. Sampling:  
Sampling is the first and crucial step of a metagenomic study in a sense that all the 
representative cells should contribute to the extracted DNA and subsequent library 
preparation for sequencing. Based on the host or environmental condition from where these 
are collected. Each sample requires separate protocols for DNA extraction (Venter et al., 
2004), (Burke, Kjelleberg, & Thomas, 2009) and (Delmont, Robe, Clark, Simonet, & Vogel, 
2011). The microbial community closely associated with the host such as the gut microbiota 
of human, fractionation or selective lysis is a suitable method of DNA extraction from the 
microbes rather than the host (Burke et al., 2009; Thomas et al., 2010).  For the metagenomic 
study of viruses from sea water, physical fractionation is suitable because a certain part of the 
total community will undergo for study. In this circumstances selective filtration, 
centrifugation or flow cytometry is suitable to enrich the target sample fraction (Angly et al., 
2006; Palenik, Ren, Tai, & Paulsen, 2009; Venter et al., 2004). The representative extraction 
of microbial DNA from the soil direct lysis might cause the loss of DNA prior to sequencing 
thus make a bias on the result. Therefore, to maximize the DNA extraction, physical 
separation or isolation of cells should be employed. Enzyme inhibitor can interfere the 
subsequent processing there for this technique might helps help to avoid coexistence 
(Delmont et al., 2011).  In some metagenomic studies where the total yield of DNA is too 
little so that it is not a suitable starting material for library preparation because modern 
sequencing technologies require high nano grams or micrograms of  DNA. To overcome this 
situation amplification of the DNA sample is a good alternative but amplification of DNA 
sample might cause a bias on result due to reagent contamination, chimera formation or bias 
during amplification (Thomas, Gilbert, & Meyer, 2012). Multiple displacement amplification 
(MDA) is a tool which uses random hexamers and phage phi29 polymerase (Lasken, 
2009).Therefore, it is essential to determine this strategy is suitable  prior to sampling of a 
metagenomic study. 
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1.6.2. Sequencing technologies for metagenomic analysis: 
The purpose of DNA sequencing is to determine the sequential order of the nucleotide bases 
on a target DNA molecule. Therefore scientist can use it for molecular breeding, cloning, 
finding pathogenic genes, and finding comparative and evolutionary studies. In that case the 
technologies should be fast, accurate, cheap and user friendly.Fredrick Snager developed the 
first DNA sequencing technologies(Sanger, Nicklen, & Coulson, 1977). The sequence 
chemistry was based on the chain termination method where Walter Gilbert developed 
another sequencing technology based on chemical modification of DNA and subsequent 
cleavage at specific bases (Liu et al., 2012). But Sanger‘s method was well accepted and 
adopted as the primary technology because it was efficient. In addition to this it used less 
radioactive molecules than Gilbert‘s method. But both of them were laborious in that time 
because they require expert handling. In 1987 Applied Biosystems introduced the first 
automatic sequencing technology machine (AB370). This technology adopted capillary 
electrophoresis to make sequencing faster and more accurate. Human genome project where 
Sanger sequencing technology was used as a main tool is a milestone for DNA sequencing 
technologies. This project stimulated the necessity of the development of the existing 
sequencing technology in different aspects such as increasing the speed parallel to accuracy, 
reducing the cost and increasing the automation. In addition to this it has accelerated the 
development of next generation sequencing (NGS) technologies (Collins, Morgan, & 
Patrinos, 2003). Consequently 454 lunched 454 in 2005 and Solexa released Genome 
Analyzer the next year and Agencourt provide the SOLiD platform. There were the primary 
NGS technologies with good performance in throughput, speed, accuracy and cost compare 
to the Sanger sequencing platform. Later Applied Biosystems purchased Agencourt on 2006, 
Roche purchased 454 on 2007 and Solexa purchased by Illumina.  
1.6.2.1.Roche 454 System: 
It is the first commercially successful NGS platform based on ‗sequencing by synthesis‘ 
chemistry. It is called ‗pyrosequencing technology‘ based on the detection of pyrophosphate 
released during nucleotide incorporation (Mardis, 2008). The template DNA with 454 
specific adaptors are single stranded and  immobile by amplification beads (figure 1.4). Then 
the dNTP‘s (dATP, dTTP, dCTP and dGTP) are incorporated to the template DNA by a PCR 
reaction with the help of ATP sulfurylase, luciferase, luciferin, DNA polymerase and 
adenosine 5′ phosphosulphate (APS) and released pyrophosphate (PPi) which equals to the 
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amount of incorporating nucleotide.After incorporating the correct complementary dNTP‘s to 
the ssDNA template bypolymersit  releases pyrophosphate (PPi) stoichiometrically. ATP 
sulfurylase quantitatively converts PPi to ATP in the  presence of adenosine 5´ 
phosphosulfate which later converts the luciferin to oxyluciferin with the help of luciferase 
enzyme. This conversion generates visible lights that are proportional to the amount of ATP 
detected by a specific camera and analyzed. In the last step of this PCR reaction apyrase 
degrades and removs the unincorporated nucleotides and ATP and the reaction continues with 
another nucleotide(Ronaghi, Uhlen, & Nyren, 1998) (figure 1.5). 454 GS FLX Titanium 
system was lunched in 2008 with increased read length and accuracy. In 2009 Roche 
upgraded their system which simplified the library preparation and data processing 
steps(Roche, 2011). 
 
Figure 1.4: Template immobilization in Roche 454 platform. A bead-bound library of ssDNA is emulsified with 
amplification reagents thus several thousands of copies of the same template sequencehave been created by PCR 
amplification. These beads are chemically crosslinked to a glass slide or deposited into PicoTiterPlate 
wells(Metzker, 2010).  
 
Figure 1.5:Pyrosequencing using Roche/454‘s Titanium platform. For understanding a single type of 2′-
deoxyribonucleoside triphosphate (dNTP) — cytosine — is shown here. When the cytosine makes a bond with 
the complementary base on the template it release a pyrophosphate (PPi) which converted to ATP by ATP 
sulphurylase. This ATP converts luciferin to oxyluciferin. This conversion generates visible lights which are 
detected by the charge coupled device (CCD) (Metzker, 2010). 
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1.6.2.2.AB SOLiD system: 
This system adopts ‗sequencing by ligation‘ where the libraries can be sequenced by 8-base 
probe ligation on a SOLiDflowcell. The probe contains ligation site on its first base, cleavage 
site on its fifth base and four different fluorescent dyes attached to the last base. These probes 
are annealed and ligated; the preferential ligation by DNA ligase for matching sequences 
leads to a signal informing of the nucleotide at that position. Prior to ligation the template 
DNA is PCR amplified and attached to a glass slide. A fluorescent signal will be captured 
during the annealing and cleavage of the last three bases of the probes. After five rounds of 
sequencing using the loader primer set the template is deduced (Huse, Huber, Morrison, 
Sogin, & Welch, 2007). SOLiD system preferentially applies on whole genome resequencing, 
targeted resequencing, transcriptome research and epigenome studies(Liu et al., 2012). 
1.6.2.3.Illumina GA/HiSeq system: 
This system adopts the technology of, sequencing by synthesis (SBS) where a library of DNA 
molecule with fixed adaptors are denatured and attached to the flowcell. A cluster of clonal 
DNA fragments form after a bridge amplification (figure 1.6). Before sequencing the cluster 
of libraries are single stranded by a linearization enzyme. Then all four kinds of dNTP‘s 
which contain differential cleavable dyes and removable blocking groups would complement 
the template one base at a time and emit a signal which is captured by a charge-coupled 
device (CCD) (figure 1.7). It can also be applied for whole-genome and region sequencing, 
transcriptome analysis, small RNA discovery, methylation profiling, and genome -wide 
protein-nucleic acid interaction analysis (M. Meyer & Kircher, 2010).HiSeq 2000 system in 
the early 2010 which adopts the same system of sequencing but with increased per run and 
introduced multiplexing where it could handle thousands of samples simultaneously. Among 
these three NGS systems IlluminaHiSeq 2000 have the biggest output with lowest reagent 
cost, SOLiD system has the highest accuracy and Roche system has the longest read 
length(Liu et al., 2012).  
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Figue 1.6: Primer immobilization and template clustering in Illumina GA platform. A primer immobilized to a 
solid support where a single molecule template is primed and bridge amplified to its adjacent primers to form 
clusters (Metzker, 2010).  
 
Figure 1.7: The four-colour cyclic reversible termination (CRT) method used by Illumina were. Following 
washing and imaging each successful incorporation of radiolebeled bases has been captured. A cleavage step 
removes the fluorescent dyes and regenerates the 3′-OH group using the reducing agent tries (2-carboxyethyl) 
phosphine (TCEP)(Metzker, 2010).  
 
 
 20 
 
1.6.2.4.Compact personal genome machine (PGM) sequencer: 
Ion Personal Genome Machine (PGM) and MiSeq were launched by Ion Torrent and Illumina 
respectively. The main advantages of these two systems is they are small in size, feature first 
turnover rates, but limited data throughput comfortable for clinical application and small 
labs(Liu et al., 2012).Ion PGM was first released in 2010 which is a first commercial 
sequencing machine that does not use fluorescence and camera scanning actually using 
semiconductor technology. By detecting the changes of pH when a nucleotide has been 
incorporated to the DNA molecule by the polymerase enzyme, PGM recognized whether the 
nucleotide is added or not. If the correct nucleotide has incorporated, change of voltage will 
be found. Change of voltage is equal to the number of nucleotides incorporated (Flusberg et 
al., 2010).  There was an outbreak of exceptionally virulent Shiga-toxin (Stx) producing 
Escherchia coli O104:H4 in Germay at the middle of the year 2011(Mellmann et al., 2011) 
and (Rohde et al., 2011). Scientist used Ion Torrent PGM and HiSeq 2000 for the whole 
genome sequencing to identify the type of E. coli. Therefore PGM shows its potentiality in 
faster sequencing  but limited throughput when there is an outbreak of new disease (Liu et al., 
2012).  
1.6.2.5.MiSeq Sequencer: 
For rapid and cost-effective genetic alasysMiSeq sequencing system is a good choice which 
is based on synthesis by sequencing technology (SBS) employed by the same company 
Illumina(Illumina, 2014a). This single instrument integrates the functions of cluster 
generation, SBS and data analysis where it can complete the sequence within a day (8 
hours)(Liu et al., 2012). The reversible terminator based method detects the incorporated 
single bases into the cluster of DNA strands. The bases are fluorescently labeled that are 
imaged upon incorporation and then cleaved to allow the incorporation of the next 
bases(Illumina, 2014a). In addition to this Nextera andTruSeq are used in this modern and 
innovative system. It has broder range of applicability which makes it promising for the next 
era of sequencing such as amplicon sequencing, clone checking, ChIP-Seq and small genome 
sequencing(Liu et al., 2012).  
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Table 1.1:comparison of different next-generation sequencing platforms. 
 Roche454‘s GS 
FLX Titanium 
Illumina/ 
Solexa‘s GA 
Life/APG‘s 
SOLiD 
HiSeq 2000* 
NGS 
chemistry*‘ ** 
Pyrosequencing** Real time** Cleavable probe 
SBL** 
Sequencing By 
Synthesis (SBS)* 
Read length 
(bases) 
330** 75 or 100** 50** Up to 150 
bases*** 
Accuracy 99.9%* N/A 99.94% (raw 
data)* 
98% (101PE)* 
*(Liu et al., 2012) 
**(Metzker, 2010) 
***(Quail et al., 2012) 
Instrument price may differ among the region. FR=Fragment run, Mate-pair run=MPR 
Table 1.2:Technical specifications of benchtop instruments MiSeq 2000 and Ion Torrent PGM (Quail et al., 
2012) 
 
*All cost calculations are based on  list  price  quotations obtained from the manufacturer and assumed expected 
sequence yield stated. 
***Includes two hours of clusters generation. 
1.6.3. Assembly: 
To obtain a longer genomic contigs from the genome of uncultured organisms than assembly 
of a short read fragments is a preferable strategy, although the development of a true 
 IlluminaMiSeq Ion Torrent PGM 
Sequence/run 1.5-2 Gb 20-50 Mb on 314 chip 
 
100-200 Mb on 316 chip 
 
1 Gb on 318 chip 
Run time 27 hours*** 2 hours 
Observed raw error 
rate 
0.80% 1.71% 
Read length Up to 150 bases ~ 200 bases 
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assembler is still an early stage. Researchers utilize two different strategies for the assembling 
of metagenomic samples: reference-based (co-assembly) and de novo assembly. If the 
reference genome of the organism which is under metagenomic study is available than 
reference based assembly is a suitable strategy for assembling of the contigs. The main 
advantages of this type of assembly is it can be done in the small machine for instance a 
laptop. They are also less time consuming. The algorithms used by these packages are fast 
and suitable for small machines. The available software packages are Newbler, AMOS, or 
MIRA (Thomas et al., 2012). As metagenomics is newly evolved sequencing techniques to 
explore the microbial ecology therefore over 90% of microbes in metagenomic data are 
unknown (Wooley, Godzik, & Friedberg, 2010). De novo assembly doesn‘t utilize any 
reference genomes for this purpose. In addition to this it uses a large machine setup and all 
are based on the de Bruijn graphs such as EULER, Abyss, Velvet, SOAP. These all are for 
single genome therefore they do not work well for metagenomic datasets, except for some 
very small datasets containing specific species (Pop, 2009).  Longer sequences make them 
easier to compare with the know genomic dataset which is better for gene 
annotation(Wommack, Bhavsar, & Ravel, 2008). The taxonomic assignment or phylogenetic 
analysis needs a specific cutoff length of the sequence, i.e., MG-RAST requires only 75 bp or 
longer for gene prediction for taxonomic binning and functional classification. Another 
objective of the assembler is to reduce data while reads are assembled to cluster rather than 
contigs. The MG - RAST pipeline uses clustering for data reduction (Thomas et al., 2012). 
None of the strategies are bias-free, but with increased accuracy.  
1.6.4. Binning:  
The process of sorting the DNA sequences into groups based on the conserved nucleotide 
composition (compositional binning) or the representative genes that represents a known 
gene in a reference database (similarity based binning) of an individual genome or genomes 
from a closely related organism. Phylopythia, S-GSOM, PCAHIER and TACAO are the 
compositional based binning algorithm, but these are not suitable for short reads as smaller 
the length the bias frequency is increased. IMG/M, MG-RAST, MEGAN, CARMA, Sort-
ITEMS and MetaPhyler are the example of similarity based binning. Programs like 
MetaCluster and PhymmBL employed both compositional and similarity based binning 
alogorithms. Self-organising maps (SOMs) or hierarchical clustering or user defined binning 
are different methods of binning the DNA sequences (Thomas et al., 2012).   
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1.6.5. Annotation: 
If the minimal length of contigs produced after the assembly of the reads are 30000 bp or 
longer and the objective of the study is to reconstruct the genome, then the existing pipeline 
for genome annotation is preferable such as RAST (Aziz et al., 2008) or IMG (Markowitz et 
al., 2009). On the other hand, if the reads are unassembled or in short contigs in length, then 
the annotation can be performed on the entire community. In this case the tools for genome 
annotation is less useful for metagenomic analysis. In these circumstances special tools for 
the annotation of the metagenomic short reads are developed.. In metagenomics study this 
type of sequences is annotated in two steps e.g., feature prediction and functional annotation 
(Thomas et al., 2012). A DNA sequence whose protein or function is unknown, but the open 
reading frames of the DNA sequences reflects the characteristics of a gene than this is called 
a putative gene. A number of algorithms have been developed to identify this CDS from the 
whole genome (Lukashin & Borodovsky, 1998). FragGeneScan(Rho, Tang, & Ye, 2010), 
MetaGeneMark(McHardy, Martin, Tsirigos, Hugenholtz, & Rigoutsos, 2007), 
MetaGeneAnnotator (MGA)/Metagene(Noguchi, Taniguchi, & Itoh, 2008) and 
Orphelia(Hoff, Lingner, Meinicke, & Tech, 2009)are used as a tool to predict the 
metagenomic CDS‘s. But these tools miss a significant subset of genes for example 
FragGeneScan which is better than most other methods gives 70% true positive rates but 
BLAST-based searches can potentially annotate these missing genes (Thomas et al., 2012).  
The pipeline for featuring the non protein coding genes require significant computational 
resources because beside the protein coding gene, there are a lot of non protein coding genes 
reside into the genome such as tRNAs(Lowe & Eddy, 1997), signal peptides (Bendtsen, 
Nielsen, von Heijne, & Brunak, 2004) or CRISPERs (Bland et al., 2007). The MG - RAST 
pipeline uses FragGeneScan (FGS) to find out the genes in short reads and similarity searches 
for ribosomal RNAs it employes SILVA (Pruesse et al., 2007), Greengenes(DeSantis et al., 
2006), and RDP (Cole et al., 2009) databases. SILVA is an online tool for the alignment of 
small and large subunit of ribosomal RNA sequences from bacteria, archaea and eukarya. 
FGA and MGA employed by both CMERA‘s RAMCAPP pipeline (Sun et al., 2011) and 
IMG/M. Beside these IMG/M uses other tools also. It is estimated that 20 to 50% 
metagenomic sequences can be annotated so there is a major computational challenge on 
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functional annotation (Gilbert et al., 2010). ORFans are the sequence which cannot be 
mapped with the know sequences may be due to error in algorithms or the gene product is 
involved in an unknown biochemical function  or may be their product (protein) may have 
structural similarity with a know protein though there is no homology between their DNA 
sequences (Godzik, 2011). KEGG (Kanehisa, Goto, Kawashima, Okuno, & Hattori, 2004), 
eggNOG(Muller et al., 2010), COG/KOG (Tatusov et al., 2003), PFAM (Finn et al., 2010) 
and TIGRFAM (Selengut et al., 2007)aremetagenomic database for functionalannotation. To 
maximize the functional annotation of metagenomic dataset it is necessary to merge them on 
a common platform because a single reference database can not cover all the biological 
functions e.g., MG-RAST and IMG/M. These platforms should share their data with other 
platforms. MG-RAST is a fully automated and data analysis pipeline, which is optimized 
between accuracy and computational efficiency for short reads. Provides feature prediction 
and functional annotation in the form of abundance profiles with quality controlling facilities 
(Thomas et al., 2012). MG-RAST has more than 12000 users and 131,567 data sets of which 
19,000 are publicly available and 58.81 Terabases analyzed as of August 2014 reflects the 
centralization and standardization of resources and data sets. IMG/M performs hidden 
Markov model (HMM) and BLASTX searches which give higher sensitivity and comparison 
is based on all Vs all genes.   The user of CAMERA (Sun et al., 2011) requires good 
knowledge on annotation of data and the analysis pipeline to interpret the result with better 
confidence level. MEGAN uses BLAST searches to visualize the annotated results as 
functional and taxonomic dendogram which makes the analysis easy (Huson, Auch, Qi, & 
Schuster, 2007).  
1.7.Nextera
®
 XT DNA sample preparation kit: 
The Nextera XT DNA sample preparation kit enables the researchers to make a sequencing 
ready library by a single tagmentation enzymatic reaction following an optimized limited 
cycle PCR reaction. This protocol is suitable to make sequencing ready libraries for bacteria, 
archaea and viruses. Those having small genome, PCR amplicons and plasmids. It requires a 
very small amount of DNA (1 ng) which makes it suitable to sequence the sample which have 
very limited availability. This sample preparation kit along with MiSeq sequencing platform 
enables the researchers to get the sample data within a single day (8 hours). Following 
tagmentation of the sample where the samples are independently fragmented and tagged with 
adaptors(figure 1.8), the sample normalization steps is very simple compare to other 
protocols. The bead-based sample normalization steps avoid the quantification of  thelibrary 
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before sample pooling because this sample preparation kit enables the researchers to prepare 
the libraries at equivalent concentrations. This sample preparation kit uses  an indexed primer 
set which enables Barcoding up to 384 samples uniquely in a single experiment. Therefore up 
to 384 samples can be pooled together and are ready for sequencing. These indexed primers 
assign the reads from to the proper sample (Illumina, 2014b).  
After the simultaneous fragmentation of the sample DNA by an enzymatic reaction following 
a limited cycle PCR reaction, both ends of the PCR sample are indexed with duel indexing 
strategy with two 8 base sequences (appendix 1).  Dual indexing is enabled by adding a 
unique Index 1 (i7) adaptors (N701-N712) adjacent to the P7 sequence and Index 2 (i5)  
adaptors (S501-S508) adjacent to the P5 sequence to each sample for the 96 samplesNextera 
XT Index Kit. Arrange index 1 (i7) primer tubes (orange caps) in horizontal and index 2 (i5) 
primers (white caps) in vertical order so that N701 is in column 1 and N712 is in column 12 
and that S501 is in row A and S508 is in row H(Illumina, 2012) (appendix 2). 
 
 
Figure 1.8:Library preparation by Nextera XT sample preparation kit. a) Binding of template DNA with Nextera 
XT transposom with adaptor. b) random fragmentation of template DNA, adaptors added on both sides. c) 
Limited cycle PCR to add sequencing primer sequences and indices.(Illumina, 2012). 
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1.8.The metagenomic RAST (MG-RAST) server: 
RAST stands for Rapid Annotation using Subsystems Technology where MG-RAST means 
RAST for metagenomes. MG-RAST server is a Minimum Information about a Genome 
Sequence (MIGS) compliant proposed by The Genomic Standards Consortium provides web-
based interface with easy access. The interface is designed in way to easy handling of 
browsing and analyzing the data. The platform of open source metagenomic RAST high-
throughput pipeline provides many sequence analysis services in addition to functional  
annotation and phylogenetic comparisons, which is based on a SEED (McNeil et al., 
2007)framework for comparative genomics by comparing both protein and nucleotide 
databases. In addition to SEED framework other open source and publicly available 
components such as NCBI BLAST(Altschul et al., 1997), other SEED subsystems, SEED nr, 
FIGfam,SQLite and Sun Grid Engine is used by this pipeline. It provides a framework so that 
the user can share others data sets for analysis, therefore it provides a new model for 
metagenomic data annotation and analysis removing the requirement the high performance 
computational set up as before.  This pipeline normalizes (removing the duplicate sequences) 
and process the raw data (in FASTA format) automatically, but the user can upload the raw 
unassembled data or assembled contigs. In the second step the screening of potential protein 
encoding genes (PEGs) present in the normalized data is performed by using BLASTX 
(Altschul et al., 1997)search where the e-value cutoff value set to 0.01 just because of 
increasing the number of potential genes. It also uses rDNA, RNA and boutique databases. 
INSDC databases sourced the SEED comprehensive non-redundant databases, other sources 
are used for searching(Overbeek et al., 2005). In the next step the computation of the matched 
data with the other databases are analyzed. The phylogenetic information stored in SEED nr 
database and similarities of the data to the ribosomal RNA database are used to compute the 
phylogenetic reconstruction of the metagenomeand functional annotation of the sequence 
were done by SEED FIGfams(F. Meyer, Overbeek, & Rodriguez, 2009)and subsyatems. The 
number of pagesis identified by subsystem comparison tool connected to subsystem. Each 
sample is scored by dividing the number of sequences that are similar to a protein in each 
subsystem and the number of sequences from the sample that are similar to any protein in a 
subsystem. The taxonomic profiles of different samples are highlighted in the taxonomic heat 
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map which is determined by the phylogenetic or phylogenomicapproces. In both cases 
samples may be grouped in a nonquantitative fashion. In case of functional annotation the 
samples are grouped by the subsystem scores, but in taxonomic assignments the predominant 
phylogenetic groups are highlighted (F. Meyer et al., 2008). 
1.8.1. P-value tool: 
It allows to carry out a statistical test to conclude if there is a ―significant‖ difference in the 
abundance in a given category across the specified group of samples. It is necessary to 
separate the samples into two or groups to perform a statistical test that determine the 
presence of the level of significance. In MG-RAST the group selection can only perform 
from the PCA analysis tool. The metagenomes were divided into five groups and stored. Each 
time after log in in this step should repeat if the samples undergoing significance tests.  Four 
types of tests are available in MG-RAST version 3 where the tests of significance are selected 
based on two criteria but they are selected automatically.  
Table 1.4:P-value test selections. This tool automatically chooses the best out of four statistical tests. Testes are 
selected based on the data type and number of groups. 
 Normalized data 
Use Parametric Testes 
Raw data 
Use non-parametric tests 
 
Tests for 2 groups 
 
Use Non-parametric Tests 
 
Mann-Whitney test 
 
Tests for 3 or more groups 
 
One way ANOVA 
 
Kruskal-Wallis test 
 
1.8.2. Normalization and standardization:  
Normalization reshapes a primary distribution with log transformation. As the biological 
variables exhibit log-normal distribution, therefore the data exhibit a normal distribution after 
normalization. In addition to this normalized data more satisfy the assumptions of 
downstream tests such as ANOVA or t-test. It is necessary to remove the inter sample 
variability among the groups to make the data more comparable. Therefore standardization is 
required, which is a kind of transformation applied to a group of distribution so that all 
exhibit same mean and standard deviation.The analysis page calculates the ordination 
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visualizations with either raw or normalized counts, at the user's option. The normalization 
procedure is as follows.  
Normalized valuei = log2 (raw counts i + 1) 
The standardized values are then calculated from the normalized values by subtracting the 
mean of each samples normalized values and dividing by the standard deviation of each 
sample normalized values. 
Standardizedi = (normalizedi  - mean (normalized i)) /stddev (normalizedi) 
As all the taxonomic and functional analysis of this study is based on normalized data and 
there are 5 groups of metagenomes under comparison so the significance test is one way 
ANOVA test.  
 
Figure 1.9: Overview of processing pipeline MG-RAST v3. In older versions where BLAST had used for 
computing similarities, here BLAT is employed which faster than the BLAST. In this pipeline after uploading 
the metadata it has normalized (it is also possible to analyze the raw data) and resulting abundance profiles are 
fed into different databases.  There the organisom and functional abundance  level is constructed (Andreas 
Wilke, 2013).  
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1.9.Significance and aim of the study: 
Human Immune Deficiency (HIV) causes AIDS in human along with some other 
mammalians. Its primary site of infection is the gut. The human gut harbor microorganisms 
which are beneficial, some are commercial and some are pathogenic. The pattern of this 
microbiota altered due various disease conditions such as diarrhea, depression, inflammatory 
bowel disease, etc. In addition to these gut microbiota can alter due to various non disease 
related conditions such as geography, food habit. Much evidence abounds of the contribution 
of microbial community in the human gut to many disease conditions. HIV causes 
inflammation in the gut wall, therefore the pattern of the gut microbiota has changed. 
Understanding of alteration of gut microbiota due to HIV is still evolving and many 
experiments are running in different part of the world considering different parameters. 
However, according to previous studies, AIDS patients experienced improved condition into 
their gut after giving a probiotic supplement.  
The aim of this project is to: 
a. Identify the gut microbiota of Swedish HIV patients. 
b. Understand whether any differences exist in the bacterial community among HIV 
infected and uninfected subjects. 
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2. Material and Methods: 
2.1.Study Design: 
The study runs on the Swedish patients who were divided into five groups, e.g., baseline, 
follow up, immune deficient, elite control and control. Baseline and follow up groups consist 
of the same patients. The difference between them was that base line is the condition prior to 
the probiotic treatment. The immune deficient group consistedwithHIV infected patients who 
developed intoAIDS. The patients in the elite control group had HIV but did not progress to 
AIDS. Lastly the control group consist of the people who did not have HIV. The stool sample 
from three people from each group were collected and stored under -20C. DNA was 
extracted from the stool of these subjects and examined for metagenomic study (figure 2.1).  
2.2.Library preparation by Nextera XT DNA sample preparation kit: 
In the first step input DNA was tagmented (tagged and fragmented) by the Nexter XT 
transposom where the transposom fragments the input DNA and add adaptor sequences to the 
ends and subsequent PCR amplification. Only 1 ng DNA is needed for tagmentation. The 
DNA concentration of each sample was determined by Qubit® Fluorometerbefore 
tagmentation so that each sample has same contribution to the pool. After the adaptor 
sequences were added to the end of the template DNA were PCR amplified to generate 
multiplexed sequencing libraries.  As the DNA concentrations were too low to make a pool 
so they undergo amplification by Illumina colony primers. The DNA amplicons were run on 
an agarose gel of 1% concentration at 80 voltages for forty minutes to get sure that they were 
successfully amplified. 
2.2.1. Determination of the concentration of input DNA: 
Prior to the tagmentation of input DNA  it is necessary to determine their concentration. 
Thus, each sample can make the same contribution to the pool ready for sequencing.  At first 
working solution was prepared by mixing Qubit reagent and Qubit buffer by 1:199 ratio.  To 
draw a standard curve two standard solutions were made by this working solution at the ratio 
of 10:190 where first one had (10 µl in volume) DNA negative and the second one had 10 µl 
DNA solution (1ng/µl). After drawing a standard curve another solution was prepared for 
each sample where the ration was 1:199 (sample:working solution). The fluorescence of each 
solution was detected and by comparing with the previous fluorescence v's concentration 
curve their DNA concentration was also measured.  
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Collection of stool sample and storage under -20
0
C 
DNA isolation, purification 
DNA quantification 
Random amplification by limited cycle PCR with 
Nextera XT DNA sample preparation kit 
Clining up PCR product 
Sequencing by MiSeq system 
Sequencs annotation 
by MG-RAST 
Patients under treatment in the hospital 
Clinical 
information of 
the patients 
Correlation 
annalysis 
Figure 2.1: The outline of the scheme. Procedure in the red boxes done by Felix Nwosu, PhD 
candidate of Professor Knut Rudi. The procedure in the green box was done in NMBU.  
Data processing 
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2.2.2. Tagmentation of input DNA: 
To make an NTA plate,5 µl of input DNA at 0.2 ng/ µl (1 ng total) was added to 10 µl of 
tagment DNA buffer and finally added to 5 µl of amplicontagment mix (ATM). The mixing 
was taken place in a 96-well TCY plate. A multichannel pipette was used to mix them well. 
Gently pipette 5 times up and down. Following centrifugation in a plate centrifuge machine 
for 1 minute, the sealed plate with a plastic seal underwent a short run on a thermocycler 
(55ºC for 5 minutes). The mix was ready for neutralization when it reaches to 10ºC. Then 5 
µl of neutralize tegment buffer was added to each well and centrifugation for 1 minute the 
palette was kept at room temperature for 5 minutes. After the incubation 15 µl of the Nextera 
PCR master mix was added to each well of NTA plate. The combination of primers was 
determined earlier and 5 µl of the primer solution was added according to the list. The tips 
was changed before going to next the row or column. Finally the orange and white caps were 
changed to avoid cross contamination in the future. The plate was centrifuged for 1 minute 
after gentle pipetting for 3-4 times and sealing with a plastic and perform a PCR reaction 
where initial denaturation was 72ºC for 3 minutes then the denaturation temperature was 
increased to 95ºC for 30 seconds. Then a cycle of (12x) of reaction was performed at the 
temperature 95ºC, 55ºC and 72ºC where the duration was 10 seconds, 30 seconds and 30 
seconds respectively. The final elongation step was carried out at the same temperature of 
72ºC for 5 minutes in order to ensure full extension of any remaining single-stranded DNA. 
The reaction was then finished and kept at the temperature between 2ºC-8ºC (up to 2 days). 
The NTA PCR product was run at 1% agarose gel for 40 minutes at 80 voltages to check its 
quality and the DNA concentration of each PCR product was measured by Qubitfluorometer.  
2.2.3. PCR clean up: 
AMPure XP bead was used topurify the library DNA in addition to this remove very short 
library fragment from the population. For this purpose at first 50 µl of NTA PCR product was 
transferred to another plate. Before mixing the PCR product with the 50 µl 1X AMPure XP 
beads and incubation for 5 minutes at room temperature, the AMPure XP beads were 
vortexed for 30 seconds. Then the plat was placed on a magnetic stand until the supernatant 
had cleared. The supernantent was removed and discarded carefully while the plate was still 
on the magnetic stand. The beads were washed twice by freshly prepared 80% ethanol by 
following steps while the plate was on a magnetic plate. 200 µl freshly prepared 80% ethanol 
was added to each well, but the beads were not resuspended and incubated for 30 seconds. 
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After incubation, supernatent was removed and discarded. The beads undergo the second 
wash following removing the excess ethanol. The plate was kept on the magnetic plate and 
air dried for 15 minutes. After air drying, the plate was removed from the magnetic plate and 
52.5 µl Resuspension Buffer (RSB) was added to each well and gently pipette for 10 times. 
After incubation for 2 minutes at room temperature, it was then placed on a magnetic plate 
again until the supernantent was cleared (at least 2 minutes). Then the clean PCR product was 
obtained after transferring the supernatant from the plate while it was still on the magnetic 
plate. Following the measurement by Qubitfluorometer, the clean PCR products were 
analyzed by running  on 1% agarose gel for 40 minutes at 80 volts. As the concentration of 
the clean PCR product was too low for pooling it undergo colony PCR by illumine colony 
primers. A PCR master mixwas firstly prepared on ice in DNA-free area of the laboratory to 
avoid any form of DNA contamination (table 2.1). The gently vortexed 6.75 µl of master-
mix, 2 µl DNA template and 16.25 µl of dH2O was then gently  poured into different wells of 
the plate. PCR reaction was performed where initial de-naturation was 95ºC for 15 minutes, 
Then a cycle of (12x) three step  PCR reaction was performed where de-naturation 
temperature continued at the same temperature for 30 minutes, 55ºC and 72ºC where the 
duration was 30 seconds in both steps. The final elongation step was carried out at the same 
temperature of 72ºC for 5 minutes in order to ensure full extension of any remaining single-
stranded DNA. The reaction was then finished and kept in the thermo-cycler at the 
temperature  10ºC. The concentration of the PCR products was measured by 
Qubitfluorometer. A pool was prepared according to the concentration of the PCR products 
where each PCR product has the same contribution to the pool. Each of them contributed 20 
ng DNA. After making a pool the mix undergoes PCR clean up process again described 
earlier. 
2.2.Sequencing, assembly and binning: 
The prepared DNA libraries were sequenced in MiSeq system installed in Norwegian 
University of Life Sciences, Norway, and assembly and binning of the sequenced data were 
done by Felix Nowsu. The data were normalized prior to analysis. Then the taxonomic and 
functional abundance was annotated by MG-RAST. All files uploaded to MG-RAST was 
named by using alphanumeric and.-_ characters without spaces. As there were no files larger 
than 50 MB or less than 1 MB so it is unnecessary to make a zip file. There are three different 
files such as sequence files (FASTA, FASTAQ or SFF formats), metadata files (filled out 
spreadsheet) and barcode files (plain text ASCHII). 
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2.3.Pre-processing of raw mixed DNA sequence: 
The raw sequence data generated from the samples have variable start and end points. Other 
undesirable characteristics of raw spectral sequences are: non-synchronization of peaks or 
peaks‘ shifts and scaling variation between samples.  In order to correct these anomalies, 
some pre-processing procedures were carried out. First, all sample sequences were aligned to 
each other, followed by trimming of the sequences to a region comprising a common start 
and end fragments. Thereafter, normalization of sequence data to remove scale variation and 
correlation optimized warping (COW) to rectify non-synchronization of the peaks were 
carried out. 
2.4.Functional abundance: 
The functional abundance count is an integer (0 or positive) based count of a particular 
function that have been detected. Sequence similarity searches were computed against a 
protein database derived from theM5NR, which provides nonredundant integration of many 
databases: GenBank, SEED, IMG, UniProt, KEGG, and eggNOGs. MG-RAST v3 now 
supports many complementary views into the data with one similarity search, including 
different functional hierarchies: SEED Subsystems, IMG terms, COG, eggNOGs, and 
ontologies such as GO (Gene Ontology Consortium, 2013). The annotated source was 
SubSystem with the maximum e-value cutoff 1e-5. The minimum % identity cut of was fixed 
in 60 which means minimum 60% identity between the selected metagenome and existing 
sBLAT sequences are under consideration. The minimum alignment length cutoffis set to 15 
which means minimum 15 aa for protein databases that predefined in MG-RAST.  
2.5.Species and strain identification and short read: 
For the analysis of metagenomic data into lower taxonomic level, it is important to resolve it 
to go down to the species level. Random reads gives a level of resolution  by which someone 
can distinguish between closely related species and strains due to the fact that random 
sequences has targeted species or strain specific genes that are not usually use in phylogenetic 
markers. Therefore phylogenetic marker cannot provide this level of resolution.  The 
comparison between very short reads (less than ~50 bp) and reads of length ~100 bp shows 
higher read length reflects a reasonable level of confidence (BLASTX bit-score of 30 and 
higher) whereas short read length results rigorous under prediction. In parallel to this, it is 
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observed that reads of length 35 bp and 100 bp are long enough to identify species (Huson et 
al., 2007) 
2.6.Lowest common ancestor analysis: 
MG-RAST provides taxonomic annotations based on Lowest Common Ancestor (LCA) 
method introduced by MEGAN (Huson et al., 2007). The advantage of this method is it 
avoids multiple annotations for a single feature. This program uses an algorithm where all 
hits are collected that assigns to the lowest common ancestor (LCA) of the set of taxa.  
Species specific sequences are annotated to taxa near the leaves of the NCBI tree. Conserved 
sequences are assigned to high-order taxa closer to the root (Huson et al., 2007)(Fig. 2.2).  
 
Figure 2.2:Species identification ofmetagenomicdata.From right to the left, three BLASTX matches obtained for 
a specific read ―r‖ from the mammoth data set, to sequences representing Campylobacter lari, Helicobacter 
hepaticus, and Wolinellasuccinogenes respectively. The LCA-assignment algorithm assigns ―r‖ to the 
taxonCampylobacterales, as it is the lowest-common taxonomical ancestor of the three matched species (Huson 
et al., 2007). 
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3. Results 
3.1. Library preparation: 
After DNA library preparation by Nextera
®
 XT DNA sample preparation kit, the libraries 
underwent analysis by agarose gel electrophoresis to perform a visual examination where a 
particular type of bands will ensure the presence of DNA libraries. The band showed a smear 
throughout different lanes which means the DNA libraries are generated with varying lengths 
and the negative control that did not give the visible band on the gel, indicates absence of 
DNA contamination in the extraction and purification procedures (figure 3.1). 
a) b)  
c) d)  
Figure 3.1: Gel run of different products during library preparation by Nextera XT DNA sample preparation kit 
from Illumina. All the gel analysis was performed on 1% agarose in 1X TAE buffer running for 40 minutes at 
80 volts. a) gel run of NutralizedTagmentAmplicons (NTA) on 1% agarose with 1X TAE buffer. Lane 1: 100bp 
ladder, lane 2-16: NTA of each sample and 17: negative control. b) Gel run of Clean amplified NTA (NTA) on 
1% agarose with 1X TAE buffer. Lane 1: 100bp ladder, lane 2-16: NTA of each sample and 17: negative 
control. c) Gel run of re-amplified Clean amplified NTA (CAN) on 1% agarose with 1X TAE buffer. Lane 1 & 
10: 100bp ladder, lane 2-9 and 11-17: reamplified NTA of each sample and 18: negative control. d) Gel run of 
reamplified Clean amplified NTA (CAN). Lane 1: 100bp ladder, lane 2: pooled reamplified CAN product, lane 
3: negative control and lane 4: discarded supernatent after step 8 during reamplified CAN processing.  
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3.2. Statistics of raw and processed data: 
There were fifteen libraries prepared for metagenomic analysis in MG-RAST. One libraries 
from elite control produced large amount of short reads. Therefore, failed QC process in MG-
RAST.The raw data comprised of 482,699,994 bp in total among the 15 metagenomes which 
comprises 4051675 sequences and after processing 398,544,691 bp were counted, which 
comprises 3574938 sequences (details in appendix 4). Which means 84155303 bp (17.43% of 
total) failed the quality control process due to some reasons, e.g., duplication (figure 3.2a,b). 
On average, there are  207690 protein features had been predicted from the processed data of 
each metagenome. Among these predicted protein features 188636 are assigned an annotation 
using at least one of the protein database shared by MG-RAST (figure 3.3b) (details in 
appendix 5).  
a)  
b)  
Figure 3.2: The bar chart represents a) the number of raw data (bp) and the processed data (bp) after data 
normalization and the amount of data that was failing in the normalization process. b)Represents the number of 
raw sequences by the raw data and the number of processed sequences after data normalization.  
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a) Predicted and identified protein features. 
 
b) Predicted and identified rRNA features. 
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c)  
Figure 3.3: The data represent predicted (red bar) and identified (yellow bar) a)protein features and b)rRNA 
features. c) identified functional categories. Predicted protein features were annotated with similarity to a 
protein of known function using M5NR database. In addition, ribosomal RNA genes were mapped to the rRNA 
databases. 
3.3. Taxonomic abundance by lowest common ancestor method: 
There were five different groups of patient stool sample from the Swedish cohort. Among the 
sixty Swedish stool specimen samples we had selected fifteen of them and each of them 
corresponding to one of these five groups. We analyzed all the data groups and compared 
using a maximum e-value cutoff 1e-5, minimum identity cutoff 95% and a minimum 
alignment length cutoff 35 measured in aa for protein and bp for RNA database. The data had 
been normalized to values between 0 and 1.  Five groups of samples, e.g., Immune deficient, 
follow-up, elite control, control and base line were analyzed and compared with each other. 
The bar charts (figure 3.4 to 3.15) used to visualize the approximate membership percentage 
within each taxonomic level included in each metagenomic sample. In addition to this we 
performed significance tests to identify taxonomic levels that are significantly different 
between these groups. The p-values were calculated using ANOVA-one-way. Data analysis 
showed that any microbial domain is not significantly different between the groups, but 
Archaea is closer to the significant level where its p value is slightly higher than P< 0.05.  It 
was observed that bacterial domain is not significant (figure 3.4) among the groups, but in its 
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lower taxonomic level, such as phylum, class, order, family, genus, species significance 
found in every level.  
3.3.1. Distribution of bacteria:  
The bacteria was the most abundant domain in all the groups, two subjects each from immune 
deficient and follow up group had higher abundance of bacterial abundance compare to other 
groups. The normalized abundance counts (NAC) of immune-deficient subjects were 0.973, 
0.937 and 0.796 (ID-945, ID-51612 and ID-51547 respectively; the NAC of the follow up 
subjects (FU-50701, FU-2605 and FU-120) were 0.966, 861 and 0.958. Their corresponding 
state in the baseline group (BL-50701, BL-2605 and BL-120) showed literally similar NAC 
e.g., 1.00, 0.87 and 0.912. The NACof C-9 (control)was 0.774 which was higher than C-7 
(control). Overall, these two subjects from the control group showed lowerNACcompared to 
all other groups (figure 3.4).  
 
Figure 3.4: The bar chart represents the normalized abundance count of  bacteria in fourteen samples. X-axis 
represents different subjects under five groups mentioned at the bottom. Y-axis represents the normalized 
abundance count score (0 to 1) of each subjects. Different subjects under same group are in same colour. 
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Figure 3.5: The bar chart presentation the normalized abundance count of  Archeae (P<0.05) in fourteen 
sampleswhich was abundant only in the Immune deficient group. All the subjects have a code number with their 
group code at the X-axis. Y-axis represents the normalized abundance count score (0 to 1) of each subjects. 
Different subjects under same group are in same colour. 
3.3.2. Phyla distribution: 
Though bacterial distribution as a domain didn‘t show any significance between thegroups, 
butit showsthe significanceat lower taxonomic levels such as bacterial phylum Firmicutes.It 
was distributed among all the groups. The NACof the C-9, C-7 and C-4allof the control 
group were 0.578, 0.558 and 0.722 respectively. A greaterNAC wasobserved in the subjects 
in all other groups. The value of NAC of EC-95 and EC-2645were  0.824 and 0.755. Whereas 
NAC of ID-945, ID-51512 and ID-51547 0.86, 0.70 and 0.787 respectively. Two subjects 
from the baseline group (BL-120 and BL-2605) showed a higher NAC compared to the 
follow up (FU-120 and FU-2605) group where same subjects participated. The NAC were 
0.877 and 0.869 in the baseline, 0.733 and 0.816 in the follow up respectively(figure 3.6a). 
Bacterial phylum Verrucomicrobia showed a different pattern of abundance counts. The NAC 
of ID-945 and ID-51612 (immune deficient group) were 0.781 and 0.754. Compared to this, 
the NACof EC-95 and C-9 were 0.634 and 0.421. The NAC of a subject which perform both 
in follow up (FU-50701) and baseline (BL-50701) was 0.058 and 0.091 respectively. The 
NAC of the immune deficient subjects was comparatively much higherthen the other 
groups(figure 3.6b). Actinobacteria was less abundant in the control group. The NACof C-9 
and C-7 (control group) were 0.273 and 0.315 (figure 3.6c). The NAC of Proteobacteria in 
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FU-50701, FU-2605, FU-120, EC-95, EC-2645, C-9, C-7, C-4, BL-50701, BL-2605 and BL-
120 were 0.738, 0.513, 0.45, 0.475, 0.454, 0.588, 0.382, 468, 0.516, 0.454 and 0.487 
respectively(figure 3.6d).  FU-2605, FU-120, EC-95, EC-2645, BL-2605 and BL-120 show 
comparatively similar NAC. The NAC of Bacteroidetes in two subjects of the follow up 
group (FU-2605 and FU-120) were 0.643 and 0.96, whereas it was 0.519 and 0.839 
respectively in BL-2605 and BL-120. Therefore, the subjects in the follow up group had 
higher NAC. 
a)  
b)  
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c)  
d)  
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e)  
Figure 3.7: Normalized abundance count of the bacterial phyla. a) Firmicutes, b) Verrucomicrobia,c) 
Actinobacteria, d) Proteobacteria and e) Bacteroidetes. All the subjects have a code number with their group 
code on the X-axis.and Y-axis: Normalized abundance count (0 to 1) of each subject. Different subjects under 
same group are in same colour. 
3.3.3. Class distribution  
There were four bacterial classes under the Firmicutes phylum distributed in different 
subjects. NAC of Clostridia in different subject groups were significantly different (P<0.05). 
It was less abundant in the control group. The NAC of C-9 and C-7 were 0.582 and 0.599 
which was lower compared to the values of other subjects. The NAC of BL-120 and BL-2605 
were 1.00 and 0.974. In contrast to this the NAC of FU-120 and FU-2605 were lowered to 
0.827 and 0.836. All the subjects whose were HIV infected had higher NAC then the C-9 and 
C-7(figure: 3.8a). The  NAC of Erysipelotrichiwasfluctuated among the subjects, even within 
a group. The NAC of BL-120 and BL-50701 were 0.463 and 0.506 respectively, whereas it 
lowers to 0.066 and 0.366 in their corresponding follow up subjects (figure 3.8b). 
Furthermore, it was also abundant in the baseline group at lower taxonomic level (figure: 
3.15). The NAC of the bacterial class Betaproteobacteriawas significantly different among 
the groups. The NAC of BL-120, BL-2605 and BL-50701 were 0.221, 0.612 and 0.699, and 
the NAC of FU-120, FU-2605 and FU-50701 were 0.125, 0.378 and 0.461 respectively. The 
NAC of the subjects in the baseline grouphad higher NAC compared to its corresponding 
subjects in the follow up group. Both subjects in the elite control group (EC-95 and EC-2645) 
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had a same NAC value which was 0.613. The NAC of ID-945, ID-51612 and ID-51547 were 
0.183, 0.157 and 0.079(figure 3.9a) which was lower compared to other groups. The NAC of 
ofGammaproteobacteria was lower subjects of baselines, elite control and immune deficient 
groups. The NAC of FU-2605 and FU-50701 were 0.521 and 1.00 respectively. In contrast to 
this, the NAC of BL-2605 and BL-50701 were 0.221 and 0.472.  The NAC of both ID-945 
and ID-50701 were 0.125. The control group showed higher NCA to the follow up groups. 
The NCA of two control subjects (C-9 and C-4) were 0.739 and 0.472 (figure 3.9b). 
a)  
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b)  
Figure 3.8: Normalized abundance count of the bacterial class under the Firmicutes phylum.  a) Clostridia and b)  
Erysipelotrichi.All the subjects have a code number (e.g., 50701) with their group code (e.g., FU for Follow up) 
on the X-axis.and Y-axis: Normalized abundance count (0 to 1) of each subject. 
a.  
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b)  
Figure 3.9: Normalized abundance count of the bacterial classes under the phylum Proteobacteria. a) 
Betaproteobacteria and d) Gammaproteobacteria. All the subjects have a code number (e.g., 945) with their 
group code (e.g., ID for Immune-deficient) on the X-axis and Y-axis: Normalized abundance count (0 to 1) of 
each subject. Different subjects under same group are in same colour. 
3.3.4. Order distribution: 
The normalized abundance count (NCA) of Clostridialeswas significantly different (P<0.05) 
among the groups. It was observed that the NAC of BL-120 and BL-2605were 1.00 and 
0.974 where as its corresponding members in follow up group FU-120 and FU-2606 had 
0.827 and 0.836 respectively which were lower thanthe baseline group. The NAC of C-9 and 
C-7 were 0.582 and 0.60 respectively, which is much lower compared to all other subjects 
(figure 3.10). The NAC of Erysipelotrichales in BL-50701 was 0.544 whereas in FU-50701 it 
was lowered to 0.371. FU-120 did not depict any NAC. In contrast to this NAC of BL-120 
was 0.491. The NAC of C-9 and C-4 were 0.048. Two subjects (ID-51612 and ID-51147) 
from the immune deficient group did not show any abundance counts (figure 3.11). 
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Figure 3.10: Distribution of Clostridiales under the phylum Firmicutes.All the subjects have a code number 
(e.g., 95) with their group code (e.g., EC for elite control) on the X-axis and Y-axis: Normalized abundance 
count (0 to 1) of each subject. Different subjects under same group are in same colour. 
 
Figure 3.11: Normalized abundance count of Erysipelotrichales in different subjects.All the subjects have a code 
number (e.g., 9) with their group code (e.g., C for Control) on the X-axis and Y-axis: Normalized abundance 
count (0 to 1) of each subject. Different subjects under same group are in same colour. 
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3.3.5. Family distribution:  
Four bacterial Family Eubacteriaceae, Lachnospiraceae, Ruminococcaceae and 
Clostridiaceae under the order Clostridiales order are abundant. Among them only 
Eubacteriaceaewas significantly different betweenthe groups. The NAC of ID-945 and ID-
51547 were 0.366 and 0.235. In contrast to this NAC of C-7 and C-4 were 0.296 and 0.408 
which shows literally similar NAC with the subjects of the immune deficient group 
mentioned earlier. C-9 (control group)didn‘t show any indication of NAC. The NAC of FU-
120 and FU-2605 were 0.727 and 0.706. The NAC of BL-120 and BL-2605 were 0.956 and 
0.912 which were higher compared to their follow up group. EC-95 and EC-2645 both from 
the elite control group had NAC of 0.934 and 0.869 which were close to the subjects in the 
baseline group (figure 3.12a). Normalized abundance count ofLachnospiraceaewithin the 
follow up group was similar. The NAC of FU-2605 andFU-120 were 0.779 and 0.809 
whereas NAC of BL-2605 and BL-120 were 0.983 and 0.978 (figure 3.12b). The NAC of 
Ruminococcaceaein C-9 and C-7 were 0.447 and 0.501. Which was comparatively higherin 
the other groups (figure 3.12c).The NAC of Clostridiaceaein ID-945, FU-50701 and BL-
50701 were 0.922, 1.00 and 0.958 respectively, which is comparatively higher within each 
group. In contrast to this FU-2605 and FU-120 had a lower NAC value which was 0.33 and 
0.235 respectively. In addition to this NAC of BL-2605 and BL-120 were 0.277 and 0.454. 
NAC of EC-95 and EC-2645 were 0.213 and 0.183 (figure 3.12d). 
a)  
0
0.2
0.4
0.6
0.8
1
1.2
ID
-9
4
5
ID
-5
1
6
1
2
ID
-5
1
5
4
7
F
U
-5
0
7
0
1
F
U
-2
6
0
5
F
U
-1
2
0
E
C
-9
5
E
C
-2
6
4
5
C
-9
C
-7
C
-4
B
L
-5
0
7
0
1
B
L
-2
6
0
5
B
L
-1
2
0
Immune 
deficient
Follow up Elite 
control
Control Base line
Immune deficient ID-945
Immune deficient ID-51612
Immune deficient ID-51547
Follow up FU-50701
Follow up FU-2605
Follow up FU-120
Elite control EC-95
Elite control EC-2645
Control C-9
Control C-7
Control C-4
Base line BL-50701
Base line BL-2605
Base line BL-120
N
o
rm
al
iz
ed
 a
b
u
n
d
an
ce
 c
o
u
n
t 
 50 
 
b)  
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d)  
Figure 3.12: Normalized abundance count of different families amongthe subjects. a) Eubacteriaceae, b) 
Lachnospiraceae, c) Ruminococcaceaeand d) Clostridiaceae.Different subjects under same group are in same 
colour. X-axis represents fourteen code number (e.g., 9) with their group code (e.g., C for Control) and Y-axis: 
Normalized abundance count (0 to 1) of each subject. 
3.3.6. Genus distribution: 
The NAC of Eubacteriuminto different groups were significantly different. The NAC of the 
immune deficient group was lower compared to the other HIV infected groups. ID-945 and 
ID-51547 had NAC of 0.182 and 0 respectively. NAC of C-9, C-7 and C-4 were 0, 0.083 and 
0.24 which is much lower than the follow up, elite control and baseline group. The NAC of 
FU-50701, FU-2605 and FU-120 were 0.876, 0.653 and 0.682. The NAC of BL-50701, BL-
2605 and BL-120 were 0.741, 0.94 and 1.00. BL-120 and BL-2605 had higher NAC compare 
to FU-120 and FU-2605. The NAC of EC-95 and EC-2645 from the elite control group were 
0.97 and 0.879 which was closer to the BL-120 and BL-2605 (figure 3.13a). Bacterial genus 
Roseburia which was highly abundant in two the baseline group members are less abundant 
in the follow up group, even absent in one follow up sample. The NAC of BL-120 and BL-
2605 were 1.00 and 0.922 which is much higher than their corresponding subjects in the 
follow up group such as FU-120 and FU-2605 had NAC of 0.757 and 0. In addition to this, 
C-9 and C-7 had much more lower NAC value such as 0.073 and 0 compare to the other 
subjects  whoes depict an abundance (fig 3.13b).The NAC of Ruminococcus was significantly 
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different among the groups. Whereas the NAC of C-9, C-7 and C-4 were 0, 0.453 and 0.287.  
Subjects from the control group showed the relatively lower NAC value than other HIV 
infected subjects (figure 3.13c). 
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c)  
Figure 3.13: NAC of different genus in different groups.a) Eubacterium, b) Rusoburia* and 
c)Ruminococcus.Different subjects under same group are in same colour.X-axis represents fourteen code 
number (e.g., 9) with their group code (e.g., C for Control) and Y-axis: Normalized abundance count (0 to 1) of 
each subject. *=  P<0.05. 
3.3.7. Species distribution: 
The NAC of two species from the genus Eubacterium weresignificantly different among the 
groups. Eubacterium rectalwas abundant in elite control samples. The NAC of EC-95 and 
EC-2645 were 0.908 and 0.658. The NAC of FU-50701, FU-2605 and FU-120 were 0.9, 
0.715 and 0.76. Compare with these subjects NAC of BL-50701, BL-2605 and BL-120 
0.807, 0.956 and 1.00 respectively, depicts that NAC was lowered in the patient 2605 and 
120. C-9, C-7 and C-4 had a lower NAC score such as 0, 0.29 and 0.074 respectively. The 
NAC score was 0 to all of the immune deficient patients(figure 3.14a). The NAC score of 
Eubacteriumsiraeumin ID-945, ID-51612 and ID-51547 were 0.118, 0.783 and 0 which 
depict this species had lower abundance. FU-50701, FU-120, C-9, C-7, BL-50701 and BL-
2605 did not show NAC score. Two subjects of elite control group such as EC-95 and EC-
2645 showed highest NAC score, which is 1.00 (figure 3.14b). 
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a)  
b)  
Figure 3.14:  NAC scores of the species of the genus Eubacterium. a)Eubacterium rectal and  b) 
Eubacteriumsiraeum. Different subjects under same group are in same colour. X-axis represents fourteen code 
number (e.g., 9) with their group code (e.g., C for Control) and Y-axis: Normalized abundance count (0 to 1) of 
each subject. 
3.3.8. Distribution of Verrucomicrobia phylum at lower taxonomic level: 
The bacterial phylum Verrucomicrobia showed an intriguing pattern of distribution where it 
is more abundant in the immune-deficient group which continues to its lower taxonomic 
level. There was only one species found in these samples which 
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isAkkermansiamuciniphilaThe NAC score of ID-945, ID-51612 and ID-51547 were 1.00, 
0.96 and 0.08.  The NAC score of EC-95, C-9 and BL-50701 were 0.797, 0.502 and 0.047. 
This species was completely absent in follow up group, BL-50701 showed very lower 
abundance (figure 3.15).  
 
Figure 3.15: The normalized abundance counts ofAkkermansiamuciniphilain fourteen subjects. Different 
subjects under same group are in same colour. X-axis represents fourteen code number (e.g., 9) with their group 
code (e.g., C for Control) and Y-axis: Normalized abundance count (0 to 1) of each subject. 
3.4. Functional abundance: 
It is necessary to understand the functional predictions along with the microbial community 
composition to understand the community information.Sequencing of total microbial 
community DNA by shotgun metagenomics provides the window for functional screening. 
Genes involved in different metabolic functions are predicted by matching the known 
functional gene sequences in the databases. Shotgun metagenomic sequencing approaches 
measures the levels of mRNA which in turn measures the level of functional genes expressed 
under specific conditions such as diet, disease etc(Lozupone, Stombaugh, Gordon, Jansson, & 
Knight, 2012).  
3.4.1. Functional category hits distribution: 
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After grouping annotated sequence sets into higher level functional groups, these sequence 
sets were compared with a number of protein database projects e.g., SEED, SubSystem, 
COGs, NOGs, KEGG orthologs can curate those functional hierarchies. Protein coding genes 
were analyzed using FragGeneScan provided by MG-RAST pipeline. The highest number of 
predicted function was 126,400 in ID-51612, followed by EC-95 which had 119,865 
predicted functions. And next to this subject BL-50701 showed 118,400 predicted functions. 
Lower number of functions predicted from the subjects of the control group (figure 3.16a). 
a)  
b)  
Figure 1.16: Distribution of a)predicted functions, b) predicted and annotated proteins at the highest level 
supported SubSystem. X-axis: percentage (%) 
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Figure 3.17: The distribution of functional categories a) metabolism, b) cellular processing and signaling and c) 
information storage and processing for at the highest level supported by NOG and COG functional hierarchies. 
The numberson the Y axisindicates the percentage (%) of reads with predicted protein functions annotated to the 
category for the given source.  
a)  
b)  
Figure 3.18: Distribution of Subsystems functional categories. A) Genes function for amino acid derivatives and 
derivatives, carbohydrates and, cell divisions and cell cycle. b) Genesfunction for membrane transport, protein 
metabolism, virulence, disease and defense and sulfur metabolism in all 14metagenomes. The y-axis represents 
the percentage of gene functioning in each category.  
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4. Discussion: 
4.1. Taxonomic and functional abundance: 
There are many factors that can alter the composition of gut microbiota over time such as 
geography, food culture, disease condition, treatment etc.Looking at the phylum level, it 
shows that the bacterial phyla Actinobacteria and Bacteroidetes interplay between them. 
Actinobacteria and Bacteroidetes abundance analysis showed that the latter has a higher 
abundance than the former among the groups except the immune-deficient group.Bacterial 
Phylum Verrucomicrobia was dominated only in immune-deficient group. 
Akkermansiamuniciphilawas the only species of this phylum that was abundant in the same 
manner throughout the taxonomic levels. One study suggested that broad spectrum antibiotic 
treatment can induce high level colonization of Verrucomicrobia(Dubourg et al., 2013)but it 
is unclear that the immune-deficient patients received any antibiotic treatment earlier. 
Gammaproteobacteriahas a higher abundance in the fecal sample of HIV infected patients 
than the healthy control (Mutlu et al., 2014)whereas the follow up group in our study showed 
higher abundance compared with its corresponding baseline group and higher than the control 
group. In contrast to these,the elite control group had lower abundance compared withall the 
group. 
Fecal microbiota of HIV infected patients in the US where the untreated HIV individuals with 
chronic infection hada significantly higher relative abundance of Prevotellaceae (Prevotella), 
Erysipelotrichaceae (Catenibacterium and Bulleidia), Veillonellaceae (Dialister and 
Mitsuokella) and Clostridium cluster XIII and genus Bifidiobacterium, 
andBacteroidaceae(Bacteroides), Rikenellaceae  (Alistipes) and 
Porphromonadaceae(Parabacteroidetes) have higher abundance levels in the gut of HIV 
negative controls(Lozupone et al., 2013).  In the present study, we found thatthe bacterial 
class Erysipelotrichi is abundant in the baseline group. In contrast to this, the follow up group 
comprised of the same patients showed lower abundance compared with baseline group. In 
addition to this the bacterial phyla Bacteroidetes was relatively abundant in the elite control 
group compared to others. Other sample groups showed some variation within the group, but 
the follow up group had increased abundance levels than the baseline group. Transgenic 
expression of DEFA5 (α-defense) causes an increase of Bacteroidetes which is significant 
and loss of Clostridia, Bacilli and Erysipelotrichias well as IL-17 producing T cells in the 
intestinal LP (Salzman et al., 2010). The substantial part of the total gut microbiota is 
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comprised of gram positive and rod shaped commensal bacterial class Clostridia which exerts 
a strong influence on the host immune system(Lopetuso, Scaldaferri, Petito, & Gasbarrini, 
2013).  According to our study, it was demonstrated that the abundance level of Clostridia 
was lower in the control group than the other HIV infected group. The immune stressed 
condition of these groups might be induced their abundance as Clostridia plays a critical role 
in the body's immune defense mechanism. However Clostridia also consists of some 
pathogenic bacteria e.g., Clostridium difficile which in turn causes difficulty in HIV affected 
patients such as diarrhea (Sivapalasingam & Blaser, 2005).Studies on gut microbiota 
suggested that normal gut microbiota is enriched with Ruminococcaceaeand 
Lanchnospiraceae families (Lozupone et al., 2012). In our study both of them have a lower 
abundance in the control groupthan the other groups. A study on vaginal microbiota after a 
treatment with probiotics demonstrated a decrease in abundance of bacterial family 
Lachnospiraceae(Ling et al., 2013). A similar pattern was observed in the gut of the subjects 
of this study between the Baseline and Follow up groups. However, there were alsointer 
individual variation.  However environment between the gut and vagina are different and 
having different environments they might be expected to show a different pattern, butthey 
showed the same pattern. The species from the family Ruminococcaceae increased in relative 
abundance with HIV infection(Lozupone et al., 2013). The inter-group variation among the 
group in our study showed that it was less abundant in the control group, while the immune 
deficient showed higher abundance than the others. The comparison between follow up and 
baseline showed that one of them experienced decreased abundance (BL-120) than the earlier 
state where as another sample (BL-2605) was in steady state and another one (BL-50701) 
showed increased abundance. So the probiotic supplement showsnoticeable impact on 
Ruminococcaceae.There was a declining pattern of Roseburiaabundance observed between 
baseline and follow up groups. Although it was demonstrated that Roseburia showed an 
increase in abundance in association to the biomarkers related to microbial translocation, it 
does not mean it is a probable cause, might be it is a reflection of HIV disease progression 
(Lozupone et al., 2014).In our study the abundance level was decreased in follow up group 
compared withbaseline group. Therefore, it is assumed that the probiotics may have an effect 
on microbial translocation. There was a declining pattern of Eubacterium observed in highly 
active antiretroviral therapy (HAART)-naive HIV-1-infected adults when they were 
supplemented with prebiotic oligosaccharides (Gori et al., 2011). Our study reflects the same 
effects, although the supplement was different as well as the patients did not receive antiviral 
therapy.  
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It is very hard to come a general conclusion about the overall effect of probiotics on the 
abundance of genes that function in the metabolism of amino acids and their derivatives 
because there are a number of metabolic reactions involved. The data did not show 
remarkable differences among these groups. Two metagenomic samples from the follow up 
group (FU-120 and FU-2605) showed decreased abundances of genes that function in the 
metabolism of amino acids and their derivatives compared with its corresponding state in 
baseline group. Studies on identical twins and germ free mice demonstrated that probiotics 
(FMP-fermented milk products) changes the expression of microbial-encoded enzymes, 
especiallyrelated to carbohydrate metabolism (McNulty et al., 2011) but in our study these 
geneswere decreased at follow up group whilethe control group showed higher abundance 
than the immune deficient group. Abundance patterns of genesthat function in protein 
metabolism were similar both in baseline and follow up group, but that does not mean that 
there was no effect of probiotics. Probiotics might restore the abundance of genes that 
function in protein metabolism, which was less abundant in early stage (baseline) because the 
control group had the similar pattern of abundance where as the elite control group had 
relatively higher abundances than the control. In addition to this, the abundance of gene that 
function in carbohydrate metabolism was higher than those functions in protein metabolism, 
leading to the assumption that the food diet of the patients in this study was carbohydrate-
rich. Genes that function in membrane transport had higher abundance in follow up group 
than their corresponding members in the baseline group. The control and follow up groups 
exhibited the same pattern while the immune deficient group had lower abundance level, 
which suggests that the probiotic supplement can improve the genesfunction in membrane 
transport.  Genesthat function in virulence, disease and defense had lower abundance in the 
immune deficient group than the other four groups which seems to be normal as the immune 
deficient group's progress to AIDS. 
4.2 Limitation of this study: 
It‘s very hard to come an affirmative conclusion from this study as the data setwas small. The 
study of human gut microbiota is a new and important topic to understand its correlation with 
different disease conditions. Therefore, availability of data is limited. In addition, 
metagenomic studies on the correlation between gut microbiota, HIV/AIDS and probiotics 
are very few. However, there are many factors that can alter the pattern of gut microbiota 
other than the aforementioned factors. One metagenomicdata from the elite control group was 
discarded due to bad quality. To get a widespread view in this area, more study is required. 
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There is very little review literature is available to make conclusions from an identified 
pattern both in taxonomic abundance and functional abundance.  
4.3 Suggestion of future work: 
To give a strong statistical power to this study, it is recommended to repeat this experiment 
with a large sample size. Since the probiotics are reported to play significant role in immune 
response regulation, it is suggested to measure different immunological markers which are 
fluctuate due to HIV infection such as CD4
+
T-cell, different pro inflammatory and anti 
inflammatorymolecules. In addition to this, detection of the markers related to microbial 
translocation through the gut wall can provide a better view of the effect of probiotic on 
translocation.  The metagenomic study of gut microbiota greatly varies on many factors such 
as sampling locations, type of samples as well as geographical  positions, food habit, lifestyle, 
age, sequencing techniques, library preparation protocols, PCR primers, how the data are 
analyzed. So combination the study can provide a wider view of the probiotic induced 
alteration of gut microbiota.  
5. Conclusion: 
Firmicuteswas the only bacterial phylum which issignificantly different among the groups, 
and less abundant in the control group. Verrucomicrobia was dominated only in the immune 
deficient group where as it had very low abundance in the follow up and the baseline group. 
Bacterial phylum Actinobacteria was less abundant than the bacteroidets. The gut microbiota 
of the HIV infected patients along with the control group. The gut microbiota alteration due 
to probiotic treatment influence the family, which might reflect the effect of the probiotics on 
the gut microbiota. Abundance of the genus Eubacterium was relatively decreased, which 
was also observed in the ART treated following prebiotic supplemented patients. A probiotic 
supplement can improve the gene functions related to membrane transport and the gene 
functioning of defense mechanism was less abundant in the immunodeficient group. These 
findings suggested a probable relationship among gut microbiota, HIV infection and 
probiotics. In addition, an extended work on immunological markers and larger sample 
sizesto elucidate a correlation with them.  
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Appendix 
Appendix 1: Different index sequences to generate sample sheets to demultiplex the samples 
Index 1 (i7) Sequence Index 2 (i5) Sequence 
N701 TAAGGCGA S501 TAGATCGC 
N702 CGTACTAG S502 CTCTCTAT 
N703 AGGCAGAA S503 TATCCTCT 
N704 TCCTGAGC S504 AGAGTAGA 
N705 GGACTCCT S505 GTAAGGAG 
N706 TAGGCATG S506 ACTGCATA 
N707 CTCTCTAC S507 AAGGAGTA 
N708 CAGAGAGG S508 CTAAGCCT 
N709 GCTACGCT   
N710 CGAGGCTG   
N711 AAGAGGCA   
N712 GTAGAGGA   
 
Appendix 2: Arrangement of index primers. Index 1 (i7) in horizontal order and Index 2 (i5) 
in vertical order. It enables 96 unique combinations  of duel indexing. 
Index 1→ 1 2 3 4 5 6 7 8 9 10 11 12 
Index 2↓ N701 N702 N703 N704 N705 N706 N707 N708 N709 N710 N711 N712 
A S501      *       
B S502     * *       
C S503     * *       
D S504     * *       
E S505     * *       
F S506     * *       
G S507     * *       
H S508     * *       
*this combination of indiceswere used in this study. 
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Appendix 3: Sample grouping with their identification number and concentration (ng/µl). 
Identification 
number 
Group Concentration 
(ng/µl) 
Identification 
number 
Group Concentration 
(ng/µl) 
120 Baseline 0.431 949 Immune 
deficient 
0.343 
120 Follow up 0.204 95 Elite 
control 
0.866 
2605 Baseline 0.14 2645 Elite 
control 
0.207 
2605 Follow up 0.11 232 Elite 
control 
0.708 
50701 Baseline Too low C4 Control Too low 
50701 Follow up 0.18 C7 Control 1.73 
51612 Immune 
deficient  
Too low C9 Control 3.05 
51547 Immune 
deficient  
0.15    
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Appendix 4:The number of base pairs, number of sequences, GC content (%) and mean 
length of each sequence (bp) before and after the quality control of 15 metagenomic data sets 
Metagenome MG-
RAST 
ID 
bp counts Sequence counts Mean GC 
content (%) 
Mean length (bp) 
  Uploaded Post QC Uploade
d 
Post 
QC 
Uploade
d 
Post 
QC 
uploaded Post 
QC 
Baseline 120 4547096
.3 
22,626,1
82 
21,010,1
26 
191,397 176,5
67 
46±9 46±
8 
118±36 118±
34 
Baseline 
2605 
4547098
.3 
32,991,6
43 
29.929,2
30 
292,270 260,7
03 
46±10 46±
9 
112±38 114±
5 
Baseline 
50701 
4547100
.3 
54,037,9
76 
49,467,0
34 
434,472 398,9
29 
48±9 48±
9 
124±35 124±
33 
Control C4 4547102
.3 
34,239,2
23 
29,237,4
41 
281,480 237,1
32 
44±11 45±
11 
121±36 123±
33 
Control C7 4547104
.3 
18,593,81
6 
15,597,4
00 
150985 12536
6 
44±9 47±8 123±35 124±
33 
Control C9 4547106
.3 
19,362,5
61 
17,880,1
72 
150,470 141,4
86 
45±8 45±
8 
128±32 126±
32 
Elite control 
2645 
4547108 34,095,9
65 
31,187,9
63 
283,273 259,2
73 
47±10 47±
9 
120±36 120±
34 
Elite control 
95 
4547110
.3 
56,576,4
19 
51,586,2
70 
470,575 428,3
25 
48±10 49±
9 
120±36 120±
34 
Follow up 
120 
4547112 39,928,9
49 
36,439,6
56 
337,656 306,6
03 
47±9 47±
9 
118±37 118±
34 
Follow up 
2605 
4547114
.3 
30,890,5
01 
27,353,1
61 
281,097 244,8
88 
47±11 47±
11 
109±37 111±
33 
Follow up 
50701 
4547116
.3 
50,660,3
54 
42,324,8
60 
408,018 339,4
28 
44±9 45±
8 
124±34 124±
32 
Immunodific
ient 51547 
4547118
.3 
16,815,9
81 
15,472,6
51 
136,070 126,4
50 
38±10 38±
10 
123±34 122±
32 
Immunodific
ient 51612 
4547120
.3 
49,254,2
42 
39,977,8
31 
442,515 353,2
21 
48±11 49±
10 
111±37 113±
33 
Immuno 
deficient 949 
4547122
.3 
22,62618
2 
21,010,1
26 
191,397 176,5
67 
46±9 46±
8 
118±36 118±
34 
Total  482,699,9
94 
398,544,6
91 
4051675 357493
8 
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Appendix 5: The number ofprocessed protein features and rRNA features, identified protein 
feature and rRNA features. Predicted protein features could be annotated with similarity to a 
protein of known function using M5NR database. In addition, ribosomal RNA genes are 
mapped to the rRNA databases. 
 
 
  Protein features rRNA features  
Metagenome MG-RAST  
ID 
Predicted Indentified Predicted Identified Identified 
functional 
categories 
 
Baseline 120 4547096.3 148,086 110,363 29,707 1,431 44421 
Baseline 2605 4547098.3 210,572 133527 47,251 2,245 46200 
Baseline 50701 4547100.3 343,555 254,320 60,222 1,894 113860 
Control C4 4547102.3 202,507 103,417 43,383 1,214 46203 
Control C7 4547104.3 107,339 56,838 23,187 694 21550 
Control C9 4547106.3 123,680 92,509 21,009 853 49816 
Elite control 
2645 
4547108.3 218,395 138,044 41,844 1,378 63783 
Elite control 95 4547110.3 360,440 235,699  69,659 2,196 104438 
Follow up 120 4547112.3 255,141 185,187 50,654 1,866 81940 
Follow up 
2605 
4547114.3 196,850 107,433 46,148 1,442 45510 
Follow up 
50701 
4547116.3 293,486 174,922 57,195  1,713 80292 
Immuno 
deficient 51547 
4547118.3 107,725 50,725 25,108 521 26657 
Immuno 
deficient 51612 
4547120.3 288,153 191,300 70,361 1,967 106257 
Immuno 
deficient 949 
4547122.3 259,431 183,361 49,330 2,410 85408 
